Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 329 of 5804
-
Could stem cells shield kidneys after severe injury?
Disease control Recruiting nowThis study aims to investigate, through the collection of valid scientific evidence necessary to determine safety and effectiveness, the potential use of Allogeneic Hope Biosciences Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) to prevent progression of trauma-induced Acute …
Phase: PHASE1, PHASE2 • Sponsor: Hope Biosciences LLC • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New stent could silence debilitating ringing in the ears
Symptom relief Recruiting nowThis study is evaluating the safety and clinical performance of the BosSTENT, a new stent designed specifically for treating pulse-synchronous tinnitus due to venous sinus stenosis. The study will evaluate the long-term safety of the BosSTENT as well as its impact on the severity…
Phase: NA • Sponsor: Sonorous NV, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Can cannabis calm War's ghosts? new trial for vets with PTSD
Symptom relief Not yet recruitingThe rationale for the use of inhalational cannabis to potentially treat PTSD symptoms is based on the many reports of cannabis attenuating PTSD symptom expression among individuals with PTSD, including veterans. Study MJP2 is intended to build off MJP-1 through use of a larger sa…
Phase: PHASE2 • Sponsor: Multidisciplinary Association for Psychedelic Studies • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Brain gene therapy aims to boost dopamine in young Parkinson's patients
Disease control Not yet recruitingThis study is looking at whether a gene therapy called AAV2-hAADC is safe and may help people with Parkinson's Disease. AAV2-hAADC is intended to increase the levels of dopamine in your brain. It contains a virus called adeno-associated virus 2 (AAV2) that has been modified to c…
Phase: PHASE1 • Sponsor: Krzysztof Bankiewicz • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Cancer cocktail aims to turn inoperable tumors into surgical wins
Disease control Not yet recruitingThe primary objective is to evaluate the efficacy and safety of Iparomlimab and Tuvonralimab Injection (QL1706, an Anti-PD-1/CTLA-4 Combined Antibody) combined with GemOX and lenvatinib as conversion therapy for Initially Potentially Resectable intrahepatic cholangiocarcinoma and…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for advanced liver cancer: drug trial targets patients with limited options
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of lenvatinib as first-line therapy in patients with Child-Pugh class B HCC who are unsuitable for curative treatment.
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Asthma drug could shield hearts after attack, new trial hopes
Disease control Recruiting nowAcute myocardial infarction (AMI) is one of the leading causes of patient mortality worldwide. Each year, over 8 million people globally die from AMI, with approximately 30% of these cases being ST-segment elevation myocardial infarction (STEMI). Despite the continuous developmen…
Phase: PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo aims to cut transfusions for blood disorder patients
Disease control Recruiting nowβ-thalassemia is one of the most common inherited hemoglobinopathies worldwide and a major public health issue that severely impacts birth quality, human health, and social progress. Currently, there are limited clinical drugs specifically designed to treat patients with β-thalas…
Phase: PHASE2 • Sponsor: Rongrong Liu • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for rare melanomas? drug combo enters phase 2 trial
Disease control Not yet recruitingThis is a prospective, single-arm, multicenter, phase II clinical trial designed to evaluate the efficacy and safety of iparomlimab and tuvoraleimab, in combination with bevacizumab, albumin-bound paclitaxel, and carboplatin as first- or second-line treatment in patients with acr…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New breathing support could save tiny lungs
Disease control Not yet recruitingRespiratory Distress Syndrome (RDS) remains the most common respiratory complication in the early postnatal period among preterm infants born before 32 weeks' gestational age. For this population, implementing lung-protective ventilation strategies is essential to shorten the dur…
Phase: NA • Sponsor: Xingwang Zhu • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a common antioxidant save newborns from deadly sepsis?
Disease control Not yet recruitingNeonatal sepsis (NS) is a life-threatening condition characterized by systemic inflammation in response to infection during the first 28 days of life. Nowadays, it is generally acknowledged that one of the critical pathogenic mechanisms involved in neonatal sepsis is oxidative st…
Phase: PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Heated chemo during surgery may fight chest tumor spread
Disease control Not yet recruitingHyperthermic intrathoracic chemotherapy (HITOC) offers a strategy to eliminate microscopic residual disease after surgical resection. Especially it is investigated to improve long-term survival in thymic epithelial tumors with pleural dissemination or recurrence. A prospective, m…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a diabetes drug stop prediabetes in its tracks?
Disease control Not yet recruitingPrediabetes is a precursor to diabetes, but compared with diabetes, much less is known about prediabetes. Prediabetes is defined based on a blood sample measuring long-term average glucose levels. In the Danish population, about 7% have prediabetes, and roughly one in five will d…
Phase: PHASE3 • Sponsor: Michael Mæng • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New pill could cut heart failure deaths when given early in hospital
Disease control Recruiting nowFACILITATE-HF is a multicenter, randomized, double-blind, placebo-controlled trial designed to determine whether initiation of finerenone during the early phase of hospitalization has beneficial effects in patients with AHF who have left ventricular ejection fraction 40% or more.
Phase: PHASE4 • Sponsor: Juntendo University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Engineered donor cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis Phase 1/2 study evaluates the safety, feasibility, and preliminary anti-tumor activity of allogeneic donor-derived CAR-NK cells in participants with advanced solid tumors. The CAR target antigen is selected for each participant after tumor profiling using a tissue biopsy and…
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Liver cancer surgery Follow-Up: could a targeted chemo shot keep cancer away?
Disease control Recruiting nowThe 5-year recurrence rate after curative hepatectomy of hepatocellular carcinoma (HCC) remains as high as 70%. According to the Chinese Liver Cancer Staging (CNLC), transarterial chemoembolization (TACE) is strongly recommended as an adjuvant therapy after curative hepatectomy, …
Phase: PHASE3 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New study aims to cut Alzheimer's diagnosis wait time by nearly a year
Diagnosis Not yet recruitingThe BioMIND (Biomarkers for the Molecular Identification of Neurodegenerative Dementia) pilot study was launched at Parkwood Hospital in response to national calls for implementation of biomarker diagnostics in Canada. It evaluated the feasibility, impact, and equity of introduci…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New hope for NMOSD attacks: immune drug added to standard care
Disease control Recruiting nowThis project is a multi-center, prospective, real-world cohort study that collects clinical data of Chinese patients with AQP4-positive NMOSD in the acute stage. It comprehensively assesses the clinical outcomes of the patients and aims to compare the clinical efficacy and safety…
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could existing cancer drugs tackle rare tumors? new trial aims to find out
Disease control Not yet recruitingThis clinical trial is looking at two drugs called dabrafenib and trametinib. Dabrafenib and trametinib are approved as standard of care treatment for adult patients with melanoma (a type of skin cancer) or lung cancer and in children with glioma (a type of brain tumour). This me…
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Stent before surgery slashes deadly leak risk in colon patients
Prevention Recruiting nowRationale: Anastomotic leakage (AL) is a severe complication of colon surgery, with an incidence of 2.7-11.9%. It is associated with long-term increased mortality, reduced quality of life, and high healthcare costs due to reoperations and prolonged hospitalization. Among colon c…
Phase: NA • Sponsor: Medisch Spectrum Twente • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC